JP2009532359A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2009532359A5 JP2009532359A5 JP2009503046A JP2009503046A JP2009532359A5 JP 2009532359 A5 JP2009532359 A5 JP 2009532359A5 JP 2009503046 A JP2009503046 A JP 2009503046A JP 2009503046 A JP2009503046 A JP 2009503046A JP 2009532359 A5 JP2009532359 A5 JP 2009532359A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- composition according
- wound
- aralkoxyadenosine
- alkoxyadenosine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 239000008194 pharmaceutical composition Substances 0.000 claims 34
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 claims 8
- 206010052428 Wound Diseases 0.000 claims 8
- 208000027418 Wounds and injury Diseases 0.000 claims 8
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 claims 6
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 claims 4
- 239000000203 mixture Substances 0.000 claims 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims 4
- WUCQGGOGHZRELS-LSCFUAHRSA-N (2r,3r,4s,5r)-2-[6-amino-2-[2-(4-chlorophenyl)ethoxy]purin-9-yl]-5-(hydroxymethyl)oxolane-3,4-diol Chemical group N=1C=2N([C@H]3[C@@H]([C@H](O)[C@@H](CO)O3)O)C=NC=2C(N)=NC=1OCCC1=CC=C(Cl)C=C1 WUCQGGOGHZRELS-LSCFUAHRSA-N 0.000 claims 3
- 239000007951 isotonicity adjuster Substances 0.000 claims 3
- 230000001737 promoting effect Effects 0.000 claims 3
- 150000003839 salts Chemical class 0.000 claims 3
- 239000002562 thickening agent Substances 0.000 claims 3
- 230000029663 wound healing Effects 0.000 claims 3
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 claims 2
- 102000008186 Collagen Human genes 0.000 claims 2
- 108010035532 Collagen Proteins 0.000 claims 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical group [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 claims 2
- DPXJVFZANSGRMM-UHFFFAOYSA-N acetic acid;2,3,4,5,6-pentahydroxyhexanal;sodium Chemical group [Na].CC(O)=O.OCC(O)C(O)C(O)C(O)C=O DPXJVFZANSGRMM-UHFFFAOYSA-N 0.000 claims 2
- 239000007853 buffer solution Substances 0.000 claims 2
- 229920002678 cellulose Polymers 0.000 claims 2
- 239000001913 cellulose Substances 0.000 claims 2
- 230000001684 chronic effect Effects 0.000 claims 2
- 229920001436 collagen Polymers 0.000 claims 2
- 150000002009 diols Chemical class 0.000 claims 2
- 239000004088 foaming agent Substances 0.000 claims 2
- 239000000243 solution Substances 0.000 claims 2
- 208000008960 Diabetic foot Diseases 0.000 claims 1
- UCRNFUVTKPHVJL-UHFFFAOYSA-N O.O.O.[Na].C(C)(=O)O Chemical compound O.O.O.[Na].C(C)(=O)O UCRNFUVTKPHVJL-UHFFFAOYSA-N 0.000 claims 1
- 229960000583 acetic acid Drugs 0.000 claims 1
- 239000013543 active substance Substances 0.000 claims 1
- 239000001768 carboxy methyl cellulose Substances 0.000 claims 1
- 229920003123 carboxymethyl cellulose sodium Polymers 0.000 claims 1
- 229940063834 carboxymethylcellulose sodium Drugs 0.000 claims 1
- 239000012362 glacial acetic acid Substances 0.000 claims 1
- 238000004519 manufacturing process Methods 0.000 claims 1
- 238000000034 method Methods 0.000 claims 1
- 239000000546 pharmaceutical excipient Substances 0.000 claims 1
- 230000036470 plasma concentration Effects 0.000 claims 1
- 229920000642 polymer Polymers 0.000 claims 1
- 239000003755 preservative agent Substances 0.000 claims 1
- 230000002335 preservative effect Effects 0.000 claims 1
- 235000019812 sodium carboxymethyl cellulose Nutrition 0.000 claims 1
- 229920001027 sodium carboxymethylcellulose Polymers 0.000 claims 1
- 239000011780 sodium chloride Substances 0.000 claims 1
- 239000012049 topical pharmaceutical composition Substances 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US78830306P | 2006-03-31 | 2006-03-31 | |
| US11/729,624 US20070232561A1 (en) | 2006-03-31 | 2007-03-29 | Pharmaceutical compositions for promoting wound healing |
| PCT/US2007/007986 WO2007123740A2 (en) | 2006-03-31 | 2007-03-30 | Pharmaceutical compositions for promoting wound healing |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2009532359A JP2009532359A (ja) | 2009-09-10 |
| JP2009532359A5 true JP2009532359A5 (enExample) | 2010-05-20 |
Family
ID=38559987
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2009503046A Withdrawn JP2009532359A (ja) | 2006-03-31 | 2007-03-30 | 創傷治癒を促進する医薬組成物 |
Country Status (6)
| Country | Link |
|---|---|
| US (2) | US20070232561A1 (enExample) |
| EP (1) | EP2001489A4 (enExample) |
| JP (1) | JP2009532359A (enExample) |
| AU (1) | AU2007241026A1 (enExample) |
| CA (1) | CA2646446A1 (enExample) |
| WO (1) | WO2007123740A2 (enExample) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2461916T3 (es) * | 2010-08-19 | 2014-05-21 | Paul Hartmann Ag | Apósito con contenido en espuma y base de pomada para la terapia por presión negativa |
| US20130295230A1 (en) * | 2012-05-04 | 2013-11-07 | Nutraceutical Corporation | Sugar-free naturally preserved stevia supplement |
| US9023826B2 (en) | 2012-10-12 | 2015-05-05 | L'oreal S.A. | Compositions containing adenosine and the hydrotropes caffeine and nicotinamide for cosmetic use |
| US9072919B2 (en) | 2012-10-12 | 2015-07-07 | L'oreal S.A. | Synergistic antioxidant cosmetic compositions containing at least one of baicalin and taxifolin, at least one of caffeine and nicotinamide, at least one of vitamin C and resveratrol and ferulic acid |
| US9018177B2 (en) | 2012-10-12 | 2015-04-28 | L'oreal S.A. | Cosmetic compositions for increasing bioavailability of the active compounds baicalin and/or vitamin C |
| US9107853B2 (en) | 2012-10-12 | 2015-08-18 | L'oreal S.A. | Compositions containing phenolic compounds and hydrotropes for cosmetic use |
| EP2906547B2 (en) | 2012-10-12 | 2022-10-26 | L'Oréal | Cosmetic compositions containing at least one hydrotrope and at least one active compound |
| US9669242B2 (en) | 2013-07-01 | 2017-06-06 | L'oreal | Compositions containing at least two phenolic compounds, a lipid-soluble antioxidant and at least one hydrotrope for cosmetic use |
| US9238090B1 (en) | 2014-12-24 | 2016-01-19 | Fettech, Llc | Tissue-based compositions |
| WO2020157633A2 (en) * | 2019-01-28 | 2020-08-06 | Core Scientific Creations Ltd. | Wound dressing compositions and methods |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3710216A1 (de) * | 1987-03-27 | 1988-10-06 | Rentschler Arzneimittel | Verwendung von dihydroergotamin und seinen salzen zur lokalen behandlung trophischer stoerungen |
| WO1994023723A1 (en) * | 1993-04-15 | 1994-10-27 | New York University | Adenosine receptor agonists for the promotion of wound healing |
| GB2318732A (en) * | 1996-11-01 | 1998-05-06 | Johnson & Johnson Medical | Wound healing compositions containing alpha-1-antitrypsin |
| IL161608A0 (en) * | 2001-10-25 | 2004-09-27 | King Pharmaceuticals Res & Dev | Synthesis of 2-aralkoxyadenosines and 2-alkoxyadenosines |
-
2007
- 2007-03-29 US US11/729,624 patent/US20070232561A1/en not_active Abandoned
- 2007-03-30 WO PCT/US2007/007986 patent/WO2007123740A2/en not_active Ceased
- 2007-03-30 AU AU2007241026A patent/AU2007241026A1/en not_active Abandoned
- 2007-03-30 EP EP07754500A patent/EP2001489A4/en not_active Withdrawn
- 2007-03-30 CA CA002646446A patent/CA2646446A1/en not_active Abandoned
- 2007-03-30 JP JP2009503046A patent/JP2009532359A/ja not_active Withdrawn
- 2007-10-17 US US11/873,909 patent/US20110144027A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2009532359A5 (enExample) | ||
| ES2625145T3 (es) | Aplicación tópica y formulación de eritropoyetina para cicatrizar heridas cutáneas | |
| ES2237104T3 (es) | Dispositivo portador de productos farmaceuticos adecuado para el aporte de compuestos farmaceuticos a superficies mucosas. | |
| CN102949709B (zh) | 一种治疗糖尿病足的外用凝胶剂及制备和应用 | |
| US20110245215A1 (en) | Transdermal delivery systems for active agents | |
| JP2013501717A5 (enExample) | ||
| TW201236701A (en) | Hydrous adhesive patch | |
| US20160331838A1 (en) | Carrier composition | |
| CN103316377A (zh) | 一种β-环糊精/羧甲基壳聚糖医用敷料及其制备方法 | |
| CA2306214C (en) | Plaster for topical use containing heparin and diclofenac | |
| CN106110389A (zh) | 一种皮肤创面用的湿性敷料及其制备方法和应用 | |
| CN1950076A (zh) | 含安溴索的局部制剂 | |
| CZ12015U1 (cs) | Přípravek pro prevenci adheze bandáľe na ránu | |
| RU2013127673A (ru) | Композиции с антибактериальной и ранозаживляющей активностью | |
| ITMI990449A1 (it) | Cerotto con spessore sottile contenente betametasone ed acido ialuronico per il trattamento di psoriasi dermatite dermatosi | |
| CN104069535B (zh) | 一种生物活性复合膜止血敷料的制备方法及用途 | |
| JP2012526099A5 (enExample) | ||
| CN1149992C (zh) | 活性化合物高度释放的抗真菌凝胶 | |
| JP4705343B2 (ja) | 経皮吸収製剤用基剤およびこれを用いた皮膚貼付製剤 | |
| JP2012106970A (ja) | 皮膚潰瘍処置用外用剤のゲル状基剤 | |
| AU2022256582B2 (en) | Methods for treating diabetic ulcer | |
| EA008686B1 (ru) | Фармацевтическая композиция в виде гидрогеля для трансдермального введения в организм действующих веществ | |
| WO2002038111A1 (en) | Pack agent in a sheet form | |
| KR20090132173A (ko) | 록소프로펜 또는 그의 염을 포함하는 경피 흡수용 조성물및 이를 포함하는 경피 투여 첩부제 | |
| CN1272071C (zh) | 创伤用外用剂 |